Maritime Metabolic & Recovery ResearchMMRR · Maritime Canada
Cart 0
Retatrutide — Maritime Metabolic & Recovery Research
TESTINGThird-party testedIndependent analytical testing is part of MMRR batch release.

Retatrutide

Manufactured in Atlantic CanadaFor research purposes only

$90.00 – $150.00

Retatrutide is an investigational synthetic peptide designed to engage the GLP-1, GIP and glucagon receptor pathways. It is studied in metabolic-signalling and energy-balance research.

SKU: MMRR-RET Category:

Description

Retatrutide is a long-acting investigational peptide engineered to act across three metabolic receptor systems: GLP-1, GIP and glucagon. These pathways are central to nutrient sensing, metabolic signalling and energy balance, which has made retatrutide an active subject of laboratory and clinical research.

MMRR Retatrutide is available in 10 mg and 20 mg vial sizes. Every MMRR batch is independently third-party tested under the MMRR testing program, including analytical identity, chromatographic purity and peptide-content evaluation, with additional quality attributes assessed where applicable.

Manufactured in Atlantic Canada. For research purposes only. No dosing or medical-use guidance is provided.

Additional information

Size

10 mg, 20 mg

Reviews

There are no reviews yet.

Be the first to review “Retatrutide”

Your email address will not be published. Required fields are marked *

Independent third-party testing

Every MMRR product batch is independently tested by a third-party laboratory before release. Core analytical testing is designed to confirm identity, chromatographic purity and peptide content, with additional impurity, moisture, residual-solvent, elemental and microbiological testing used where applicable to the product and batch.

Testing is product- and batch-specific. MMRR does not treat a purity percentage as a substitute for identity, content or microbiological testing.

Read about MMRR testing ↗

Related products